Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19

Completed

• Conditions: Coronavirus

• Registration Number: NCT04373148
• Lead Sponsor: Stanford University

Brief Summary

The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults and children diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-08
• Study First Submitted: 2020-04-30
• Study First Submitted QC: 2020-04-30
• Study First Posted: 2020-05-04
• Primary Completion: 2022-05-31
• Study Completion: 2022-05-31
• Status Verified: 2022-06
• Last Update Submitted: 2022-06-13
• Last Update Posted: 2022-06-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 316

Inclusion Criteria

• Adults (18 years and older) and children with confirmed COVID-19 (RT-PCR diagnosis).
• Adults (18 years and older) and children without COVID-19 for controls (who test negative for COVID-19 but may have viral symptoms)

Exclusion Criteria

• Patients with special risks attendant to venipuncture will be excluded.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Testing Immunity to SARS-CoV-2 over time	1 year

Secondary Outcome Measures

Name	Time	Method
Testing the virus over time	1 year

Trial Locations

Locations (2)

Stanford Health Care - ValleyCare; 🇺🇸 Pleasanton, California, United States

Stanford University, Hospital, and Clinics; 🇺🇸 Stanford, California, United States